Literature DB >> 19713980

Hepatitis C: Should antiviral therapy be offered to elderly patients?

Annarosa Floreani.   

Abstract

relatively little information exists on the prognosis for elderly patients with chronic hepatitis C (CHC). Moreover, the majority of randomized, clinical trials of hepatitis C treatment exclude elderly patients. Findings from a 2009 clinical study address risk of hepatocellular carcinoma, life expectancy and the influence of antiviral therapy in elderly patients with CHC.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19713980     DOI： 10.1038/nrgastro.2009.138

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


  8 in total

1.  Limitation of combination therapy of interferon and ribavirin for older patients with chronic hepatitis C.

Authors:  Yoshiaki Iwasaki; Hiroshi Ikeda; Yasuyuki Araki; Toshiya Osawa; Keiji Kita; Masaharu Ando; Toshinari Shimoe; Kouichi Takaguchi; Noriaki Hashimoto; Toshitsugu Kobatake; Minoru Tomita; Mitsuhiko Kawaguchi; Haruhiko Kobashi; Kohsaku Sakaguchi; Yasushi Shiratori
Journal:  Hepatology       Date:  2006-01       Impact factor: 17.425

2.  Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C?

Authors:  Annarosa Floreani; Eliseo Minola; Isabella Carderi; Francesco Ferrara; Erik Rosa Rizzotto; Vincenzo Baldo
Journal:  J Am Geriatr Soc       Date:  2006-03       Impact factor: 5.562

Review 3.  Viral hepatitis in older adults.

Authors:  E L Marcus; R Tur-Kaspa
Journal:  J Am Geriatr Soc       Date:  1997-06       Impact factor: 5.562

4.  Hepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?

Authors:  Dominique Thabut; Sophie Le Calvez; Vincent Thibault; Julien Massard; Mona Munteanu; Vincent Di Martino; Vlad Ratziu; Thierry Poynard
Journal:  Am J Gastroenterol       Date:  2006-06       Impact factor: 10.864

5.  National prevention of hepatocellular carcinoma in Japan based on epidemiology of hepatitis C virus infection in the general population.

Authors:  Hiroshi Yoshizawa; Junko Tanaka; Yuzo Miyakawa
Journal:  Intervirology       Date:  2006       Impact factor: 1.763

Review 6.  Prevention of hepatitis C virus-related hepatocellular carcinoma.

Authors:  E Jenny Heathcote
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

7.  The prevalence of hepatitis C virus infection in the United States, 1999 through 2002.

Authors:  Gregory L Armstrong; Annemarie Wasley; Edgar P Simard; Geraldine M McQuillan; Wendi L Kuhnert; Miriam J Alter
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

8.  Necessities of interferon therapy in elderly patients with chronic hepatitis C.

Authors:  Kenji Ikeda; Yasuji Arase; Yusuke Kawamura; Hiromi Yatsuji; Hitomi Sezaki; Tetsuya Hosaka; Norio Akuta; Masahiro Kobayashi; Satoshi Saitoh; Fumitaka Suzuki; Yoshiyuki Suzuki; Hiromitsu Kumada
Journal:  Am J Med       Date:  2009-05       Impact factor: 4.965
  8 in total
  2 in total

1.  Burden of Hepatitis C Virus Infection Among Older Adults in Long-Term Care Settings: a Systematic Review of the Literature and Meta-Analysis.

Authors:  Kimberly J Alvarez; Arlene Smaldone; Elaine L Larson
Journal:  Curr Infect Dis Rep       Date:  2016-03       Impact factor: 3.725

2.  Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more.

Authors:  Edoardo G Giannini; Monica Basso; Vincenzo Savarino; Antonino Picciotto
Journal:  Dig Dis Sci       Date:  2010-09-18       Impact factor: 3.199
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.